Bio-Techne Corp. (TECH) said its Ella benchtop immunoassay platform has received CE-IVD marking and is now available for clinical use across the European Union.
The CE-IVD certification allows hospitals, clinical laboratories and diagnostic developers in Europe to use the Ella platform for in-house test development, clinical trials and other translational applications. The company said the milestone expands Ella's use beyond research settings into clinical environments.
Bio-Techne said the CE-IVD marking supports its long-term strategy to advance precision diagnostics and standardized biomarker detection.
For comments and feedback contact: editorial@rttnews.com
Business News
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.